Algebris (Uk) LTD Thermo Fisher Scientific Inc. Transaction History

Algebris (Uk) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$541.52 - $599.02 $249,640 - $276,148	461 Added 41.38%	1,575 $870,000
Q1 2024 May 07, 2024	SELL	$528.82 - $599.43 $132,205 - $149,857	-250 Reduced 18.33%	1,114 $647,000
Q4 2023 Feb 13, 2024	BUY	$431.41 - $532.94 $215,273 - $265,937	499 Added 57.69%	1,364 $723,000
Q3 2023 Nov 13, 2023	BUY	$498.29 - $574.41 $66,272 - $76,396	133 Added 18.17%	865 $437,000
Q2 2023 Aug 11, 2023	SELL	$508.46 - $591.13 $116,945 - $135,959	-230 Reduced 23.91%	732 $381,000
Q1 2023 May 12, 2023	SELL	$535.0 - $604.82 $2,675 - $3,024	-5 Reduced 0.52%	962 $554,000
Q4 2022 Feb 13, 2023	BUY	$484.71 - $571.37 $468,714 - $552,514	967 New	967 $532,000

2,832

334M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $204B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Algebris (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Algebris (Uk) LTD with notifications on news.